OVARIAN CANCER and US

An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.

“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein

Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label mesothelin. Show all posts
Showing posts with label mesothelin. Show all posts
Thursday, March 22, 2012

ImmunoCellular Therapeutics Licenses Novel Immunotherapeutic Target EphA2 from University of Pittsburgh - MarketWatch

›
ImmunoCellular Therapeutics Licenses Novel Immunotherapeutic Target EphA2 from University of Pittsburgh - MarketWatch ImmunoCellular The...
Sunday, March 11, 2012

abstract: Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 (includes graphic/study of 23 patients)

›
 Highlights (in study of 23 patients) ► Three new markers were compared to CA125 for lead time to ovarian cancer recurrence. ► HE4 elevat...
Sunday, July 04, 2010

HE4 and Mesothelin: Novel Biomarkers of Ovarian Cancer

›
"Addition of mesothelin to this combination did not show any improvement in the sensitivity. Conclusions: As a single marker, HE4 had t...
›
Home
View web version

Sandi Pniauskas Ovarian Cancer and Us

OvarianCancerandUs
View my complete profile
Powered by Blogger.